Biggest News Aggregation in the World
📰 Plenary News

Page 6 - Plenary News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Plenary. Real-time updates on events, politics, business and more.

House of Reps adjourn plenary to May 16 | National Accord Newspaper

By JOY ADARA, Abuja - The House of Representatives has adjourned its plenary until May 16, 2023. The Clerk of the House, Dr Yahaya Danzaria, announced this in a statement issued on Tuesday in Abuja. He said that the earlier adjourned date of May 9, will no longer stand as it would not allow members
Nigeria General Abuja Federal Capital Territory Yahaya Danzaria National Assembly House Of Representatives

Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Compared to Chemotherapy Alone in Patients With Advanced or Unresectable Biliary Tract Cancer

Results from Phase 3 KEYNOTE-966 to be presented at AACR 2023 Annual Meeting during Clinical Trials Plenary Session, included in official meeting press program and published simultaneously in The... | April 16, 2023
United States San Francisco Robin Kate Kelley Merck Co Inc Statement Of Merck Co Inc Exchange Commission

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Merus N.V.: Merus Announces Publication of an Abstract on Petosemtamab Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma for Plenary Session Oral Presentation at the AACR Annual Meeting 2023 and Provides a Program and Regulatory Upda

- Robust 36% overall response rate (ORR) in 42 evaluable patients - 6 months median duration of response with 17 patients still on treatment as of Nov. 28, 2022 data cutoff - End-of-Phase meeting
San Diego United States United Kingdom Andrew Joe Company Conference Call Us Food Drug Administration

Agenus' Botensilimab in Combination with Balstilimab Shows 33% Durable Responses in Ovarian Cancer

Data presented at plenary session of Society of Gynecologic Oncology Meeting  Patients treated suffered from platinum resistant/refractory ovarian cancer Previous PD-1/CTLA-4... | March 27, 2023
Bruno Bockorny Society Of Gynecologic Oncology Harvard University Harvard Medical School Beth Israel Deaconess Medical Center Company Phase

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science